Propensity score analysis of vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention using thrombin hemostatic patch-facilitated manual compression

Journal of Invasive Cardiology

Volumn 19, Issue 4, 2007, Pages 164-170

  Applegate, Robert J ^a   Sacrinty, Matthew T ^b   Kutcher, Michael A ^b   Baki, Talal T ^b   Gandhi, Sanjay K ^b   Santos, Renato M ^b   Kahl, Frederic R ^b   Little, William C ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; EPTIFIBATIDE; HEPARIN; HIRULOG;

ANTICOAGULATION; ARTICLE; CARDIOVASCULAR RISK; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; FEMORAL ARTERY; HEART CATHETERIZATION; HEART MUSCLE REVASCULARIZATION; HEMOSTASIS; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MOBILIZATION; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; SAFETY; SCORING SYSTEM; THROMBIN HEMOSTATIC PATCH FACILITATED MANUAL COMPRESSION; VASCULAR ACCESS;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; EARLY AMBULATION; FEMALE; FEMORAL ARTERY; HEART CATHETERIZATION; HEMATOMA; HEMOSTATICS; HUMANS; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; PRESSURE; RISK ASSESSMENT; THROMBIN; TIME FACTORS; VASCULAR DISEASES;

EID: 34147167500     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Gruchevsky M, Manubens C, Hardy S, et al. Reduced time to ambulation in the diagnostic catheterization patient. Am J Cardiol 2004;94 (Suppl 6A):202E.
2. Elian D, Guetta V, Alcalai R, et al. Early mobilization after diagnostic cardiac catheterization with the use of a hemostatic bandage containing thrombin. Cardiovasc Revasc Med 2006;7:61-63.
3. Mlekusch W, Dick P, Haumer M, et al. Arterial puncture site management after percutaneous transluminal procedures using a hemostatic wound dressing (Clo-Sur P.A.D.) versus conventional manual compression: A randomized controlled trial. J Endovasc Ther 2006;13:23-31.
4. Najjar SF, Healey NA, Healey CM, et al. Evaluation of poly-n-acetyl glucosamine as a hemostatic agent in patients undergoing cardiac catheterization: A double-blind, randomized study. J Trauma 2004;57:S38-S41.
5. Palmer BL, Gantt DS, Lawrence ME, et al. Effectiveness and safety of manual hemostasis facilitated by the SyvekPatch with one hour of bedrest after coronary angiography using six-French catheters. Am J Cardiol 2004;93:96-97.
6. Nader RG, Garcia JC, Drushal K, Pesek T. Clinical evaluation of the SyvekPatch in consecutive patients undergoing interventional, EPS and diagnostic cardiac catheterization procedures. J Invasive Cardiol 2002;14:305-307.
7. Tavris DR, Dey S, Albrecht-Gallauresi B, et al. Risk of local adverse events following cardiac catheterization by hemostasis device use: Phase II. J Invasive Cardiol 2005;17:644-650.
8. Holcomb JB, Pusateri AE, Harris RA, et al. Dry fibrin sealant dressing reduce blood loss, resuscitation volume, and improve survival in hypothermic coagulopathic swine with grade V liver injuries. J Trauma 1999;47:233-240.
9. Froud T, Yrizarry JM, Alejandro R, Ricordi C. Use of D-STAT to prevent bleeding following percutaneous transhepatic intraportal islet transplantation. Cell Transplant 2004;13:55-59.
10. Applegate RJ, Sacrinty M, Kutcher MA, et al. Propensity score analysis of vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention 1998-2003. Catheter Cardiovasc Interv 2006;67:556-562.
11. Applegate RJ, Draughn T, Yarbrough WD, Little WC. Restenosis of a sirolimus drug-eluting stent: Aorto-ostial involvement of the proximal right coronary artery. Catheter Cardiovasc Interv 2006;67:391-395.
12. American College of Cardiology Website. American College of Cardiology-National Cardiovascular Data Registry Module Version 3.0. American College of Cardiology 2003.
13. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
14. D'Agostino RB. Tutorial in biostatistics - Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998;17:2265-2281.
15. Brener SJ, Lytle BW, Casserly IP, et al. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circ 2004;109:2290-2295.
16. Fischer TH, Connolly R, Thatte HS, Schwaitzberg SS. Comparison of structural and hemostatic properties of the poly-n-acetyl glucosamine Syvek patch with products containing chitosan. Microsc Res Tech 2004;63:168-174.
17. Thatte HS, Zagarins S, Khuri SF, Fischer TH. Mechanisms of poly-n-acetyl glucosamine polymer-mediated hemostasis: Platelet interactions. J Trauma 2004;57:S13-S21.
18. Fischer TH, Thatte HS, Nichols TC, et al. Synergistic platelet integrin signaling and factor XII activation in poly-n-acetyl glucosamine fiber-mediated hemostasis. Biomaterials 2005;26:5433-5443.
19. Konstance R, Tcheng JE, Wightman MB, et al. Incidence and predictors of major vascular complications after percutaneous coronary intervention in the glycoprotein IIb/IIIa platelet inhibitor era. J Intervent Cardiol 2004;17:65-70.